A Study of Olanzapine in Participants With Bipolar Disorder.

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Total Enrollment

3000 participants

Study Classification

OBSERVATIONAL

Study Start Date

2025-10-30

Study Completion Date

2027-09-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study aimed to identify treatment patterns in patients with bipolar disorder receiving olanzapine according to demographic and clinical characteristics and to evaluate the effectiveness of education on weight gain, a side effect of olanzapine, in preventing weight gain.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Olanzapine Treatment of Patients With Bipolar I Disorder

NCT00510146

Depression, Bipolar

COMPLETED PHASE3

Efficacy of Olanzapine Monotherapy for Treatment Bipolar Ⅰ Depression

NCT01303601

Bipolar Disorder Depression, Bipolar

COMPLETED PHASE4

Olanzapine vs. Comparator and Placebo in the Treatment of Patients With Bipolar I Disorder

NCT00094549

Bipolar Disorder

COMPLETED PHASE4

Safety and Efficacy of Olanzapine in the Long-term Treatment for Bipolar I Disorder, Depressed

NCT00618748

Bipolar I Disorder

COMPLETED PHASE3

Olanzapine Versus Active Comparator in the Treatment of Bipolar I Disorder

NCT00034580

Bipolar Disorder

COMPLETED PHASE4

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Bipolar Disorder

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Olanzapine

As this is a non-interventional study designed to collect data as part of routine clinical practice, the selection and dosage of medication, treatment period, and whether or not to change it are all based on the clinician's judgment.

Intervention Type DRUG

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients who have signed the informed consent after receiving information about the purpose and method of this study.
* Patients diagnosed with bipolar disorder and scheduled to receive olanzapine.
* Patients who understand the contents of the survey and can answer the questions directly.

Exclusion Criteria

* Female patients who are pregnant, have childbearing potential, or are breastfeeding.
* Has received an investigational product within 12 weeks from the study enrollment or has plans to participate in another clinical trial during the participation of this study.
* Other subjects who are considered inappropriate to participate in this study by the judgment of the investigator.

Minimum Eligible Age

19 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No